John D. Carlin is an intellectual property attorney who focuses on patents – primarily with regard to patent litigation, licensing and technology transfers, intellectual property due diligence investigations, and client counseling.
John has litigated cases, negotiated agreements, and counseled clients on matters involving a wide range of technologies, and various pharmaceutical chemistries, formulations, and manufacturing processes.
- Represented Adams Respiratory against Mutual Pharmaceuticals on patents related to Adams’ highly successful Mucinex® product
- Represented Otsuka Pharmaceuticals against Teva Pharmaceuticals, Barr Laboratories, Apotex, Sandoz, and Sun Pharmaceuticals on patents related to Otsuka’s Abilify® anti-psychotic product
- Represented IBM against Fair Isaac on claims of patent infringement, trade secret misappropriation, breach of contract, and copyright infringement involving IBM’s launch of its next-generation business process management software
- Represented AstraZeneca against Andrx, Genpharm, Dr. Reddy, and Schwartz Pharma on patents related to omeprazole and its formulations
- Defended Combe against allegations of misappropriation of trade secrets, unfair competition, trademark infringement, false designation of origin, breach of express and implied contracts, and fraud, brought by Brandwynne
- Defended Mars against accusations of trade dress infringement and dilution, brought by Hershey Foods, related to the color orange, as used for candy packaging.
- J.D. New York University School of Law 1992
- B.S.E.E. magna cum laude University of Michigan 1989
Bar Admissions : New York, U.S. Patent and Trademark Office
Court Admissions :
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. Court of Appeals for the Federal Circuit
Rate : $$$$